What is Hangzhou Tigermed Consulting Co., Ltd.’s 1-month forecast?

Meyka AI projects 3347.HK could trade near $45.16 in the next month, a move of 5.76% compared to today’s price.

What is Hangzhou Tigermed Consulting Co., Ltd.’s 1-year forecast?

By 2027, 3347.HK is forecasted to reach $39.04, reflecting a -8.57% change from the current level.

What is Hangzhou Tigermed Consulting Co., Ltd.’s 5-year forecast?

The 2030 projection for 3347.HK is $50.41, which represents a potential 18.05% change.

What is the 7-year outlook for Hangzhou Tigermed Consulting Co., Ltd.?

Over the next 7 years, 3347.HK could trade around $59.79, showing a 40.04% move from today’s price.

Can Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) reach $65 by 2030?

Meyka AI’s 2030 forecast places 3347.HK at $50.41, making it unlikely to reach $65 by 2030 under current market conditions.

Hangzhou Tigermed Consulting Co., Ltd.

Get $10 bonus on your first $100 deposit for 3347.HK

3347.HK•HKSE

Healthcare

Medical - Diagnostics & Research

Get $10 bonus on your first $100 deposit for 3347.HK

HK$42.70

HK$-1.28(-2.91%)

Hong Kong Market opens in 36h 36m

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Stock Forecast & Price Predictions

Get the latest Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted PriceHK$45.16

Change↑ HK$2.46 (5.76%)

Quarterly Forecast

Predicted PriceHK$49.20

Change↑ HK$6.50 (15.22%)

Yearly Forecast

Predicted PriceHK$39.04

Change↓ HK$-3.66 (-8.57%)

3 Years Forecast

Predicted PriceHK$44.82

Change↑ HK$2.12 (4.97%)

5 Years Forecast

Predicted PriceHK$50.41

Change↑ HK$7.71 (18.05%)

7 Years Forecast

Predicted PriceHK$59.79

Change↑ HK$17.09 (40.04%)

Hangzhou Tigermed Consulting Co., Ltd. Stock Forecast Summary

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) stock is currently priced at $42.70. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $45.16.

In the long term, 3347.HK shows a bearish trend. The 2027 forecast points to $39.04 (-8.57% change), while the 2031 forecast suggests $50.41 (18.05% change). Looking 7 years ahead, projections estimate the stock could trade near $59.79, a 40.04% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bullish

Long-Term Outlook

Bearish

This mix indicates that Hangzhou Tigermed Consulting Co., Ltd. stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on 3347.HK based on our AI price forecasts. Enter your investment amount and select a target date.

Based on your investment of HK$1,000.00 in Hangzhou Tigermed Consulting Co., Ltd. and holding until April 4th, 2027, you could make a potential HK$85.66 loss, reflecting a -8.6% ROI over the next 365 days.

Investment Amount (HKD)

HK$

HODL Until

$Shares Bought

23.4192

@ HK$42.70/share

~Forecast Price

HK$39.04

1-year AI forecast

$Est. Portfolio Value

HK$914.34

HK$85.66 loss

%ROI

-8.6%

return on investment

Hangzhou Tigermed Consulting Co., Ltd. yearly Price Forecast Chart

Explore the yearly forecast chart for 3347.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Hangzhou Tigermed Consulting Co., Ltd. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for 3347.HKForecasting details for 3347.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Hangzhou Tigermed Consulting Co., Ltd. Stock Forecast 2026

The forecast for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) in 2026 suggests a price of $39.04, representing a -8.57% move from today’s price.

Average Target: $39.04

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Hangzhou Tigermed Consulting Co., Ltd. Stock Forecast 2030

By 2030, Meyka AI projects 3347.HK could trade near $50.41, showing a potential 18.05% compared to current levels.

Average Target: $50.41

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Hangzhou Tigermed Consulting Co., Ltd..

Hangzhou Tigermed Consulting Co., Ltd. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for 3347.HK points to a price around $59.79, which is a projected 40.04% move from today’s level.

Average Target: $59.79

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Hangzhou Tigermed Consulting Co., Ltd.’s ability to maintain market leadership.